Research Update Event - 16th May 2024
Join us for a free Research Update Event in person in Canberra or via live webinar
Retina Australia will be hosting a Research Update Event on 16th May 2024 at the John Curtin School for Medical Research (JCSMR) at the Australian National University in Canberra. It will also be streamed live for viewers around the country who cannot attend in person.
- Discover emerging treatments in geographic atrophy, a late stage of age-related macular degeneration (AMD) – by Dr Carla Abbott, Centre for Eye Research Australia and University of Melbourne
- Learn about how targeting inflammation can protect against retinal degeneration – by Dr Adrian Cioanca, Australian National University
- Hear how using the message of exercise may prevent blindness – by Nick Bariesheff, Australian National University
Event details
DATE: Thursday 16 May 2024
TIME: A light lunch will be available from 12pm
Presentations (and the live webinar) will commence at 12.30pm to 2.15pm.
There will be an option to take a tour of the research lab facilities post presentations.
LOCATION: Streamed LIVE online or attend in person at:
Finkel Lecture Theatre
John Curtin School for Medical Research
Australian National University
131 Garran Rd, Acton ACT 2601
This event is free.
REGISTER NOW:
Presentation summaries
Dr Carla Abbott (pictured on the right) will present on the emerging treatments in geographic atrophy, a late stage of age-related macular degeneration (AMD). For the first time, there are now approved treatments for geographic atrophy, also known as atrophic AMD, available in the USA, and it is expected these treatments will also be considered by regulators in other jurisdictions including Australia in the coming months. Having access to potential new treatment options means it is important for clinicians to be thinking about who these treatments are best suited for and how best to discuss these new options with patients. This talk will cover the diagnosis of atrophic AMD, the potential new treatments on the horizon, the patients that these treatments are best suited for and collaborative management approaches between optometry and ophthalmology. The talk will also discuss opportunities for patients to be involved in cutting-edge clinical trials for AMD.
Dr Adrian Cioanca (pictured on the right) was awarded a Retina Australia grant in 2023 for the research project “Using RNA-silencing to tackle neuroinflammation in retinal degeneration“. Its aim was to develop a new treatment for retinal degeneration using a type of RNA called silencer RNA. Now that the project is completed, we will hear from Dr Cioanca about his findings and project outcomes.
Nick Bariesheff, PhD student at Clear Vision Research Lab at the Australian National University, will present his PhD research talk that he made in the 3-Minute-Thesis (3MT) competition last year titled “Using the Message of Exercise to Prevent Blindness” for which he was awarded the runner up prize. In the 3MT, you must present your PhD research in under 3 minutes to a non-expert audience, with only a single static powerpoint slide to support your talk.
Key Event Sponsor
Event Hosts